MD 12 Panel Multi-Drug Test Card

Comprehensive Testing, Trusted Results, and Effective

What is a MD 12 Panel Multi-Drug Test?

The MD 12 Panel Multi-Drug Test Card is one of the most popular tools for reliable on-site drug screening, providing quick, multi-drug detection with results in under five minutes. Its FDA Approval and CLIA Waived status make it a trusted choice in a range of environments, from workplaces to schools. With a long 12-24 month shelf life, this kit combines accuracy, ease of use, and cost efficiency, helping organizations and individuals alike get dependable results.

Key Features and Benefits

• User-Friendly Design: The simple dip-and-read procedure makes testing straightforward and accessible to all.
• Fast Results: Obtain test outcomes in minutes, allowing for quick decision-making.
• FDA Approved & CLIA Waived: Compliance with regulatory standards ensures accuracy and quality control.
• Extended Shelf Life: Can be stored for up to 24 months, making it a practical choice for inventory management.

Select from our range of CLIA Waived MD 12 Panel Multi-Drug Test Kits, tailored to detect different combinations of substances:

• M-DOA-1124
  • Cocaine - COC, Marijuana - THC, Opiates 2,000ng - OPI, Amphetamine - AMP, Methamphetamine - mAMP, Phencyclidine - PCP, Benzodiazepines - BZO, Barbiturates - BAR, Methadone - MTD, Ecstasy - MDMA, Oxycodone - OXY, Propoxyphene (Darvon, Darvocet, Novrad)
  • Propoxyphene (Darvon, Darvocet, Novrad): On November 2010 the FDA concluded that PPX caused “serious toxicity to the heart", even when used at therapeutic doses.
• M-DOA-3124
  • Cocaine - COC, Marijuana - THC, Opiates 2,000ng/mL, Amphetamine - AMP, Phencyclidine - PCP, Benzodiazepines - BZO, Barbiturates - BAR, Methadone - MTD, Tricyclic Antidepressants - TCA, Ecstasy - MDMA, Oxycodone - OXY, Buprenorphine - BUP, Suboxone
  • Buprenorphine: a semisynthetic derivate of opiod that is used to treat opioid addiction. Some of the known formulations are Cizdol, Subutex, Suboxone, Zubsolv, Bunavail.
• M-DOA-3125F
  • Marijuana - THC, Cocaine - COC, Morphine - MOP, Amphetamine - AMP, Methamphetamine - MET, Fentanyl - FEN 200ng/mL, Benzodiazepines - BZO, Barbiturates - BAR, Methadone - MTD, Ecstasy - MDMA, Oxycodone - OXY, Buprenorphine - BUP
  • Fentanyl (Cut-Off Level 200ng/mL): Fentanyl is a synthetic opioid that is 50-100 times stronger than morphine. Pharmaceutical fentanyl was developed for pain management treatment of cancer patients, applied in a patch on the skin. Because of its powerful opioid properties, Fentanyl is also diverted for abuse. Fentanyl is added to heroin to increase its potency, or be disguised as highly potent heroin. Note. *For Forensic Use Only
• M-DOA-6125
  • Cocaine - COC, Marijuana - THC, Opiates 300ng/mL, Amphetamine - AMP, Methamphetamine - MET, Phencyclidine - PCP, Benzodiazepines - BZO, Barbiturates - BAR, Methadone - MET, Ecstasy - MDMA, Oxycodone - OXY, Buprenorphine - Suboxone
  • Buprenorphine: a semisynthetic derivate of opiod that is used to treat opioid addiction. Some of the known formulations are Cizdol, Subutex, Suboxone, Zubsolv, Bunavail.

How to Use the MD 12 Panel Multi-Drug Test Card – Step-by-Step Procedure

The MD 12 Panel Multi-Drug Test Card by Medical Disposables Corp offers a quick and reliable way to screen for multiple drugs with minimal preparation.

Collect the Sample:

• Obtain a urine sample from the donor using a clean, *disposable collection cup. For optimal results, use a cup with an integrated temperature strip.

Check the Temperature:

• If the collection cup includes a temperature strip, verify that the urine is within the correct temperature range, typically between 90-100°F (32-38°C). This step helps confirm sample authenticity.

Prepare the Test Card:

• Remove the MD 12 panel drug test card from its packaging, handling it carefully to avoid contamination.

Submerge the Test Strips:

• Take off the cap at the bottom of the test card to reveal the test strips.
• Dip the test strips into the urine sample carefully, without exceeding the arrow markers on the test card. Submerging past the arrows may flood the test and invalidate the results.

Observe the Reaction Time:

• Allow the test card to sit for three to five minutes as the strips react with the sample. Ensure the card remains upright to avoid interfering with the test process.

Interpret the Results:

• Wait for the results and read them within 5 minutes, ensuring not to exceed this time frame.
• Look for lines in the Control (C) area. A line in this area confirms that the test is working correctly. Next, check the Test ( T) area for each drug panel. The presence or absence of lines will indicate a negative or positive result, as outlined in the instruction guide provided with the kit.

Dispose Safely:

• Once testing is complete, dispose of the test card and collection cup according to local health and safety regulations. Avoid touching the test area, as it may contain traces of the substances detected.

Note: Be sure to read and interpret the results within the specified time window, as results may fade or change after this period. Following these steps carefully will help ensure the accuracy and reliability of your 12 Panel Drug Test results.

Order your MD 12 Panel Multi-Drug Test Card today to protect your workplace, maintain safety, and ensure peace of mind with one of the most trusted and comprehensive drug screening solutions available.

Note: CLIA WAIVED MD Multi Drug Test Cards
Our MD Panel Multi-Drug Test Cards are CLIA Waived, which means they meet the standards set by the Clinical Laboratory Improvement Amendments (CLIA) for use in non-laboratory settings. These tests are approved for point-of-care use, ensuring high accuracy and reliability in workplace, clinical, and home environments. By choosing CLIA Waived products, you are selecting tests that adhere to strict regulatory standards while simplifying the testing process for any user.

* Disposable Collection Cup Sold Separately